Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ge Healthcare Technologies Inc. (GEHC) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ge Healthcare Technologies Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1932393.
Total stock buying since 2023: $152,429.
Total stock sales since 2023: $16,188,199.
Total stock option exercises since 2023: $10,623,233.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 2,000 | $185,080 | 0 | $0 |
2024 | 1,315 | $100,623 | 113,417 | $9,301,621 | 100,457 | $6,623,407 |
2023 | 748 | $51,806 | 86,238 | $6,701,498 | 78,220 | $3,999,826 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-02 | 0 | $0 | 2,000 | $185,080 | 0 | $0 |
2024-11 | 0 | $0 | 4,477 | $388,205 | 13,275 | $536,310 |
2024-08 | 0 | $0 | 21,758 | $1,803,990 | 0 | $0 |
2024-05 | 1,315 | $100,623 | 87,182 | $7,109,426 | 87,182 | $6,087,097 |
2023-07 | 0 | $0 | 15,609 | $1,201,971 | 13,275 | $536,310 |
2023-03 | 0 | $0 | 70,629 | $5,499,527 | 64,945 | $3,463,516 |
2023-01 | 748 | $51,806 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-18 | Newcomb George A. (Chief Accounting Officer) | Sale | 2,000 | 92.54 | 185,080 |
2024-11-06 | Rott Roland (CEO, Imaging) | Sale | 3,577 | 86.48 | 309,338 |
2024-11-05 | Rackliffe Philip (CEO, AVS) | Sale | 900 | 87.63 | 78,867 |
2024-11-05 | Rott Roland (CEO, Imaging) | Option Ex | 13,275 | 40.40 | 536,310 |
2024-08-14 | Stacherski Kenneth R. (Ch. Supply Chain & Serv. Ofc.) | Sale | 19,008 | 83.22 | 1,581,845 |
2024-08-07 | Westrick Thomas J. (CEO, Patient Care Solutions) | Sale | 2,750 | 80.78 | 222,145 |
2024-05-15 | Makela Jan (CEO, Imaging) | Sale | 66,955 | 81.54 | 5,459,510 |
2024-05-15 | Makela Jan (CEO, Imaging) | Option Ex | 66,955 | 71.73 | 4,802,481 |
2024-05-13 | Makela Jan (CEO, Imaging) | Sale | 20,227 | 81.57 | 1,649,916 |
2024-05-13 | Makela Jan (CEO, Imaging) | Option Ex | 20,227 | 63.51 | 1,284,616 |
2024-05-01 | Jimenez Frank R (GC & Corporate Secretary) | Buy | 1,315 | 76.52 | 100,623 |
2023-07-31 | O'neill Kevin Michael (CEO, PDx) | Sale | 15,609 | 77.00 | 1,201,971 |
2023-07-31 | O'neill Kevin Michael (CEO, PDx) | Option Ex | 13,275 | 40.40 | 536,310 |
2023-03-14 | Makela Jan (CEO, Imaging) | Sale | 70,629 | 77.86 | 5,499,527 |
2023-03-14 | Makela Jan (CEO, Imaging) | Option Ex | 64,945 | 53.33 | 3,463,516 |
2023-01-23 | Culp H Lawrence Jr | Buy | 748 | 69.26 | 51,806 |
Insider trading activities including stock purchases, stock sales, and option exercises of GEHC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ge Healthcare Technologies Inc. (symbol GEHC, CIK number 1932393) see the Securities and Exchange Commission (SEC) website.